On July 26, 2026, Syntron Bioresearch, Inc. appeared on the leak site operated by the DragonForce ransomware group. The California-based manufacturer of rapid diagnostic tests for fertility, ovulation, and pregnancy has confirmed it was hit by a ransomware attack in which internal files were allegedly exfiltrated. The number of individuals whose information was contained in those files remains unknown, as neither the leak-site listing nor any public company notification has disclosed specific record counts or data types beyond “internal files.”
Already exposed?
You can’t unleak data. You can take away what it’s worth.
A leaked record is where it starts, not where it ends. What turns it into your front door is the look-up sites publishing your address beside your name — and those are what an AI reads when somebody asks about you. The free scan shows you both. We write to 580 companies.
See what is exposed about you — free scan →Watch Syntron Bioresearch
Get alerted the next time Syntron Bioresearch files a breach with any US regulator — the filing, dated and sourced. A free single-company slice of Signals; no account needed.
We’ll email you only about Syntron Bioresearch’s future breach filings and how to watch a whole vendor list — not general marketing. Unsubscribe any time.
Reported Details from the Listing
The DragonForce leak site states that Syntron Bioresearch suffered a ransomware intrusion and that attackers successfully exfiltrated internal company files. The posting does not specify which systems were compromised, the volume of data taken, or the exact categories of information involved. Public reporting on the incident remains limited because the primary disclosure is the ransomware group’s own leak page. The company, which holds FDA licensing as a Medical Device Establishment and ISO certification, produces over-the-counter diagnostic readers and tests used by healthcare providers and individual consumers.
Why This Matters for You and Your Family
When a medical diagnostics manufacturer loses control of internal files, the exposure can reach far beyond corporate records. Patient information, customer orders, employee personnel files, and partner contracts are common in such environments. Even if the leak site has not yet published samples, the mere confirmation that data was allegedly stolen creates immediate risk for anyone who has used Syntron’s ovulation, pregnancy, or fertility tests. Medical and personal health details are among the most sensitive categories because they can be used for identity theft, insurance fraud, or targeted scams that feel deeply personal.
Your family’s exposure is not abstract. If your name, address, date of birth, or payment information ever touched Syntron’s systems, that data may now sit in an attacker’s archive waiting to be used or sold.